Pharma companies developing vaccines with efficacy against Omicron variants will gain competitive advantage in China, says GlobalData
The WHO has urged China to increase adoption of mRNA vaccines, given their high efficacy against variant strains.
The WHO has urged China to increase adoption of mRNA vaccines, given their high efficacy against variant strains.
SEZABY is a benzyl alcohol-free and propylene glycol-free formulation of phenobarbital sodium powder for injection
Cell sorting technology supports researchers advancing new therapies
OmiCrisp has been developed with support from Centre for Cellular And Molecular Platforms C-CAMP-InDx Program
The supplemental New Drug Application is based on results from the landmark EMPA-KIDNEY phase III trial
The AGE1.CR.pIX cell line is derived from primary cells of a duck embryo and was designed to comply with health authority guidelines
NDM disorders are a group of rare, inherited neuromuscular disorders with an estimated prevalence of 1 case per 100,000 inhabitants in Spain, and are characterized by the inability to relax muscles following voluntary contraction (myotonia)
Dr. Grant brings to the table significant BOD governance, global business development, and corporate development expertise
A study by Agharkar Research Institute (ARI), Pune, has discovered that a protein secreted from intervertebral disc cells induces disc regeneration in aged degenerated discs
Biocytogen will provide a license to Hansoh Pharma for their selected fully human antibody molecules
Subscribe To Our Newsletter & Stay Updated